Form 4 for IQV IQVIA
Accepted 2025-01-30 00:00:00 ET · period of report 2025-01-28 · accession 0001478242-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-30 | 2025-01-28 | IQV | Bruehlman Ronald E | See Remarks | A - Grant | $0.00 | +6,286 | 37.7K | +20% | $0 |
| D | 2025-01-30 | 2025-01-28 | IQV | Bruehlman Ronald E | See Remarks | F - Tax | $203.43 | -2,201 | 35.5K | -6% | -$447.7K |
| D | 2025-01-30 | 2025-01-28 | IQV | Bruehlman Ronald E | See Remarks | A - Grant | $0.00 | +31.6K | 31.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | A | A | 6,286 | $0.00 | 37,677 | D | — | — | (F1) Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on January 28, 2025. |
| 2 | Common | Common Stock | 2025-01-28 | F | D | 2,201 | $203.43 | 35,476 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2025-01-28 | A | A | 31,603 | $0.00 | 31,603 | D | $203.43 · — to 2035-01-28 | 31,603 Common Stock | (F3) This stock appreciation right vests in three annual installments beginning on January 28, 2026. |